{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:55:22Z","timestamp":1781528122830,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"DOI":"10.1038\/s41390-026-05087-0","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:19:19Z","timestamp":1781525959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted efficacy of BCG Hsp70\u2013anti-CD123 immunoconjugate in childhood acute myeloid leukemia"],"prefix":"10.1038","author":[{"given":"Xiao-Ling","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"5087_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ajh.27625","volume":"100","author":"S Shimony","year":"2025","unstructured":"Shimony, S., Stahl, M. & Stone, R. M. Acute myeloid leukemia: 2025 update on diagnosis, risk-stratification, and management. Am. J. Hematol. 100, 860\u2013891 (2025).","journal-title":"Am. J. Hematol."},{"key":"5087_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/09553002.2023.2267640","volume":"100","author":"CM Milder","year":"2024","unstructured":"Milder, C. M. et al. Third mortality follow-up of the Mallinckrodt uranium processing workers, 1942\u20132019. Int. J. Radiat. Biol. 100, 161\u2013175 (2024).","journal-title":"Int. J. Radiat. Biol."},{"key":"5087_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12672-025-01797-9","volume":"16","author":"U Ebinama","year":"2025","unstructured":"Ebinama, U. & Binsah, G. Revolutionizing acute myeloid leukemia treatment: a systematic review of immune-based therapies. Discov. Oncol. 16, 89 (2025).","journal-title":"Discov. Oncol."},{"key":"5087_CR4","doi-asserted-by":"publisher","first-page":"1135350","DOI":"10.3389\/fonc.2023.1135350","volume":"14","author":"R Masetti","year":"2023","unstructured":"Masetti, R. et al. Chemotherapy-free treatment for acute promyelocytic leukemia: the pediatric view of a revolutionary tale. Front Oncol. 14, 1135350 (2023).","journal-title":"Front Oncol."},{"key":"5087_CR5","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.3390\/vaccines9121497","volume":"9","author":"KH Gupta","year":"2021","unstructured":"Gupta, K. H., Nowicki, C., Giurini, E. F., Marzo, A. L. & Zloza, A. Bacterial-based cancer therapy (BBCT): Recent advances, current challenges, and future prospects for cancer immunotherapy. Vaccines (Basel) 9, 1497 (2021).","journal-title":"Vaccines (Basel)"},{"key":"5087_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.intimp.2012.07.022","volume":"14","author":"X-L Li","year":"2012","unstructured":"Li, X.-L., Sun, L.-R., Wang, Z. & Sun, X.-F. The preparation of leukemia cell vaccine expressing BCG heat shock protein 70 andanti-leukemia effect in vitro. Int. Immunopharmacol. 14, 235\u2013242 (2012).","journal-title":"Int. Immunopharmacol."},{"key":"5087_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.intimp.2012.11.010","volume":"15","author":"X-L Li","year":"2013","unstructured":"Li, X.-L., Zhao, C.-L., Dong, Q. & Sun, L.-R. Enhancement of immunogenicity of murine lymphocytic leukemia cells bytransfection with BCG heat shock protein 70 gene. Int. Immunopharmacol. 15, 1\u20135 (2013).","journal-title":"Int. Immunopharmacol."},{"key":"5087_CR8","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1158\/0008-5472.CAN-17-3024","volume":"78","author":"M Rahmani","year":"2018","unstructured":"Rahmani, M. et al. Cotargeting BCL-2 and PI3K induces BAX-dependent mitochondrial apoptosis in AML cells. Cancer Res. 78, 3075\u20133086 (2018).","journal-title":"Cancer Res."},{"key":"5087_CR9","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.exphem.2007.07.001","volume":"35","author":"D van Gosliga","year":"2007","unstructured":"van Gosliga, D. et al. Establishing long-term cultures with self-renewing acute myeloid leukemia stem\/progenitor cells. Exp. Hematol. 35, 1538\u20131549 (2007).","journal-title":"Exp. Hematol."},{"key":"5087_CR10","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/joim.13283","volume":"289","author":"PS Woll","year":"2021","unstructured":"Woll, P. S. & Jacobsen, S. E. W. Stem cell concepts in myelodysplastic syndromes: lessons and challenges. J. Intern Med. 289, 650\u2013661 (2021).","journal-title":"J. Intern Med."},{"key":"5087_CR11","doi-asserted-by":"publisher","first-page":"102526","DOI":"10.1016\/j.coph.2025.102526","volume":"82","author":"B Wang","year":"2025","unstructured":"Wang, B., Reville, P. K. & Abbas, H. A. Therapeutic hurdles in acute myeloid leukemia: Leukemic stem cells, inflammation and immune dysfunction. Curr. Opin. Pharm. 82, 102526 (2025).","journal-title":"Curr. Opin. Pharm."},{"key":"5087_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3324\/haematol.2022.280800","volume":"108","author":"P Stelmach","year":"2023","unstructured":"Stelmach, P. & Trumpp, A. Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica 108, 353\u2013366 (2023).","journal-title":"Haematologica"},{"key":"5087_CR13","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s12015-021-10308-6","volume":"18","author":"NA Long","year":"2022","unstructured":"Long, N. A., Golla, U., Sharma, A. & Claxton, D. F. Acute myeloid leukemia stem cells: Origin, characteristics, and clinical implications. Stem. Cell Rev. Rep. 18, 1211\u20131226 (2022).","journal-title":"Stem. Cell Rev. Rep."},{"key":"5087_CR14","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.3390\/cells11152395","volume":"11","author":"Z Wang","year":"2022","unstructured":"Wang, Z. & Cormier, R. T. Golden syrian Hamster models for cancer research. Cells 11, 2395 (2022).","journal-title":"Cells"},{"key":"5087_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009367","volume":"13","author":"EM Zawidzka","year":"2025","unstructured":"Zawidzka, E. M. et al. Tumor-specific CD8+ T cells from the bone marrow resist exhaustion and exhibit increased persistence in tumor-bearing hosts as compared with tumor-infiltrating lymphocytes. J. Immunother. Cancer 13, e009367 (2025).","journal-title":"J. Immunother. Cancer"},{"key":"5087_CR16","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.3390\/ijms26062716","volume":"26","author":"AM Erasha","year":"2025","unstructured":"Erasha, A. M., El-Gendy, H., Aly, A. S., Fern\u00e1ndez-Ortiz, M. & Sayed, R. K. A. The role of the tumor microenvironment (TME) in advancing cancer therapies: Immune system interactions, tumor-infiltrating lymphocytes (TILs), and the role of exosomes and inflammasomes. Int. J. Mol. Sci. 26, 2716 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"5087_CR17","first-page":"539","volume":"34","author":"MZ Arshad","year":"2024","unstructured":"Arshad, M. Z. et al. Frequency and aberrant CD marker profile of acute leukaemias. J. Coll. Phys. Surg. Pak. 34, 539\u2013544 (2024).","journal-title":"J. Coll. Phys. Surg. Pak."},{"key":"5087_CR18","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1158\/1078-0432.CCR-23-1962","volume":"30","author":"J Lownik","year":"2024","unstructured":"Lownik, J., Boiarsky, J., Birhiray, R., Merchant, A. & Mead, M. Sequencing of anti-CD19 therapies in the management of diffuse large B-cell lymphoma. Clin. Cancer Res. 30, 2895\u20132904 (2024).","journal-title":"Clin. Cancer Res"},{"key":"5087_CR19","doi-asserted-by":"publisher","first-page":"e010511","DOI":"10.1136\/jitc-2024-010511","volume":"13","author":"JJ Luke","year":"2025","unstructured":"Luke, J. J. et al. Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors. J. Immunother. Cancer 13, e010511 (2025).","journal-title":"J. Immunother. Cancer"},{"key":"5087_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1200\/JCO.21.01595","volume":"40","author":"AJ Lamble","year":"2022","unstructured":"Lamble, A. J. et al. CD123 expression is associated with high-risk disease characteristics in childhood acute myeloid leukemia: A report from the children\u2019s oncology group. J. Clin. Oncol. 40, 252\u2013261 (2022).","journal-title":"J. Clin. Oncol."},{"key":"5087_CR21","first-page":"46","volume":"75","author":"HM Kantarjian","year":"2025","unstructured":"Kantarjian, H. M. et al. Acute myeloid leukemia management and research in 2025. CA Cancer J. Clin. 75, 46\u201367 (2025).","journal-title":"CA Cancer J. Clin."},{"key":"5087_CR22","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.3390\/cancers14133073","volume":"14","author":"S Jiang","year":"2022","unstructured":"Jiang, S. & Redelman-Sidi, G. BCG in bladder cancer immunotherapy. Cancers (Basel) 14, 3073 (2022).","journal-title":"Cancers (Basel)"},{"key":"5087_CR23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1089\/jir.2024.0259","volume":"45","author":"MR Ataherian","year":"2025","unstructured":"Ataherian, M. R., Hafezi, N., Ferdosi-Shahandashti, E. & Abdinia, F. S. IFN-\u03b3 approaches in tumor suppression, its challenges, and future directions: A review of recent advances. J. Interferon Cytokine Res. 45, 164\u2013173 (2025).","journal-title":"J. Interferon Cytokine Res"},{"key":"5087_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02294-x","volume":"24","author":"P Wawrzyniak","year":"2025","unstructured":"Wawrzyniak, P. & Hartman, M. L. Dual role of interferon-gamma in the response of melanoma patients to immunotherapy with immune checkpoint inhibitors. Mol. Cancer 24, 89 (2025).","journal-title":"Mol. Cancer"},{"key":"5087_CR25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov, H., Orhan, A., Christensen, J. P. & G\u00f6genur, I. Cytotoxic CD8+ T cells in cancer and cancer immunotherapy. Br. J. Cancer 124, 359\u2013367 (2021).","journal-title":"Br. J. Cancer"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05087-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05087-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05087-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:19:20Z","timestamp":1781525960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05087-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":25,"alternative-id":["5087"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05087-0","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained from the guardians of all pediatric patients involved in this study prior to sample collection, in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}